FDA Accepts Priority Review NDA for Potential Niemann-Pick Disease Type C Drug
source: pixabay.com

FDA Accepts Priority Review NDA for Potential Niemann-Pick Disease Type C Drug

According to a story from globenewswire.com, the US Food and Drug Administration (FDA) recently accepted the New Drug Application (NDA) for arimoclomol. This application is for the use of the…

Continue Reading FDA Accepts Priority Review NDA for Potential Niemann-Pick Disease Type C Drug
September is Charcot-Marie-Tooth Disease Awareness Month: Spreading Rare Disease Awareness
source: pixabay.com

September is Charcot-Marie-Tooth Disease Awareness Month: Spreading Rare Disease Awareness

September is recognized as Charcot-Marie-Tooth disease (CMT) Awareness Month. Although this illness is one of the most widespread inherited genetic disorders, there is still a significant need to spread awareness…

Continue Reading September is Charcot-Marie-Tooth Disease Awareness Month: Spreading Rare Disease Awareness
Experimental Treatment for Diffuse Intrinsic Pontine Glioma Earns Rare Pediatric Disease Designation
source: pixabay.com

Experimental Treatment for Diffuse Intrinsic Pontine Glioma Earns Rare Pediatric Disease Designation

According to a story from BioSpace, Ziopharma Oncology, Inc. has recently announced that its investigational therapy Ad-RTS-hIL-12 with veledimex (also called Controlled IL-12) has been given Rare Pediatric Disease designation…

Continue Reading Experimental Treatment for Diffuse Intrinsic Pontine Glioma Earns Rare Pediatric Disease Designation
Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete
source: pixabay.com

Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete

According to a story from BioSpace, the biopharmaceutical company Clene Nanomedicine, Inc., has recently announced that it has completed the process of enrollment patient participants in its upcoming phase 2…

Continue Reading Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete
Recently Approved Treatment for Dravet Syndrome Continues to Show Impacts in Phase 3 Trial
source: pixabay.com

Recently Approved Treatment for Dravet Syndrome Continues to Show Impacts in Phase 3 Trial

According to a story from BioSpace, the biopharmaceutical company Zogenix, Inc., has recently announced the release of results from a phase 3 clinical trial testing the company's drug fenfluramine (marketed…

Continue Reading Recently Approved Treatment for Dravet Syndrome Continues to Show Impacts in Phase 3 Trial
September is Pulmonary Fibrosis Awareness Month: Spreading Rare Disease Awareness
source: pixabay.com

September is Pulmonary Fibrosis Awareness Month: Spreading Rare Disease Awareness

According to a story from Newswise, September is recognized as Pulmonary Fibrosis Awareness Month. This includes idiopathic pulmonary fibrosis (IPF), or disease without an identifiable cause. In the midst of…

Continue Reading September is Pulmonary Fibrosis Awareness Month: Spreading Rare Disease Awareness
September 15th is World Lymphoma Awareness Day: Spreading Blood Cancer Awareness
source: pixabay.com

September 15th is World Lymphoma Awareness Day: Spreading Blood Cancer Awareness

September 15th, 2020 is recognized as World Lymphoma Awareness Day. This day is dedicated to spreading awareness about lymphoma and falls in the context of Blood Cancer Awareness Month, which…

Continue Reading September 15th is World Lymphoma Awareness Day: Spreading Blood Cancer Awareness
September 13-19 is Mitochondrial Disease Awareness Week: Spreading Rare Disease Awareness
source: pixabay.com

September 13-19 is Mitochondrial Disease Awareness Week: Spreading Rare Disease Awareness

The third week of September is recognized annually as Mitochondrial Disease Awareness Week. This global event is held in order to increase awareness of mitochondrial disease in the medical community…

Continue Reading September 13-19 is Mitochondrial Disease Awareness Week: Spreading Rare Disease Awareness
September 13-19 is Balance Awareness Week: Spreading Vestibular Disorders Awareness
source: pixabay.com

September 13-19 is Balance Awareness Week: Spreading Vestibular Disorders Awareness

This year, September 13-19 is being recognized as Balance Awareness Week. Organized by the Vestibular Disorders Association, the goal of this campaign is to help spread awareness among both the…

Continue Reading September 13-19 is Balance Awareness Week: Spreading Vestibular Disorders Awareness
COVID-19 and Heart Damage: What You Need to Know
source: pixabay.com

COVID-19 and Heart Damage: What You Need to Know

According to a story from Buzzfeed News, the coronavirus/COVID-19 pandemic continues to present new surprises and challenges to the medicine and science communities. In a recent interview, Wayne Sebastianelli, who…

Continue Reading COVID-19 and Heart Damage: What You Need to Know
Pulmonary Arterial Hypertension Drug Adempas Achieves Primary Endpoint in Recent Trial
source: pixabay.com

Pulmonary Arterial Hypertension Drug Adempas Achieves Primary Endpoint in Recent Trial

According to a story from Pharmaceutical Business Review, the pharmaceutical company Bayer has recently announced encouraging findings from its phase 4 clinical study. This trial was testing the drug riociguat…

Continue Reading Pulmonary Arterial Hypertension Drug Adempas Achieves Primary Endpoint in Recent Trial
An Experimental Diagnostic for Neuroblastoma has Earned Rare Pediatric Disease Designation
source: pixabay.com

An Experimental Diagnostic for Neuroblastoma has Earned Rare Pediatric Disease Designation

According to a story from BioSpace, the radiopharmaceutical company Clarity Pharmaceuticals, Inc. has announced recently that its experimental diagnostic 64Cu-SARTATE™ has earned Rare Pediatric Disease designation from the US Food…

Continue Reading An Experimental Diagnostic for Neuroblastoma has Earned Rare Pediatric Disease Designation